Categorization of cutaneous epithelioid angiomatous nodule as epithelioid hemangioma or angiolymphoid hyperplasia with eosinophilia: Clinicopathologic, immunohistochemical, and molecular analyses of seven lesions

J Cutan Pathol. 2022 Sep;49(9):765-771. doi: 10.1111/cup.14246. Epub 2022 May 10.

Abstract

Background: The status of cutaneous epithelioid angiomatous nodule (CEAN) as a distinct entity remains controversial. This study investigated the relationship between CEAN and epithelioid hemangioma/angiolymphoid hyperplasia with eosinophilia (ALHE).

Methods: Data of seven lesions with CEAN features from four cases (Cases 1-4: 61-year-old, 76-year-old, 53-year-old, and 21-year-old men, respectively) were investigated.

Results: Cases 1 and 2 showed multiple lesions in the head and neck region, but Cases 3 and 4 showed solitary lesions on the back and scalp, respectively. Moreover, the histopathologic findings of the lesions of Cases 1 and 2 were consistent with those of conventional epithelioid hemangioma or classic cutaneous ALHE. Diffuse immunoexpression of FOSB was observed in Cases 1 and 2, but FOSB split signals were absent in break-apart fluorescence in situ hybridization (FISH). In contrast, the histopathologic findings of the lesions of Cases 3 and 4 were consistent with those of cellular-type epithelioid hemangiomas. Diffuse immunoreactivity for c-FOS was observed in Cases 3 and 4, and split signals of FOS were present in break-apart FISH in Case 3.

Conclusions: This study showed that the seven tumors with CEAN features could be reclassified under the epithelioid hemangioma/ALHE group, although the small sample size is a limitation.

Keywords: FOS; FOSB; angiolymphoid hyperplasia with eosinophilia; cutaneous epithelioid angiomatous nodule; epithelioid hemangioma.

MeSH terms

  • Angiolymphoid Hyperplasia with Eosinophilia* / diagnosis
  • Angiolymphoid Hyperplasia with Eosinophilia* / pathology
  • Hemangioma* / pathology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Proto-Oncogene Proteins c-fos / analysis
  • Vascular Neoplasms*

Substances

  • Proto-Oncogene Proteins c-fos